Skip to content

Feasibility of High Intensity Interval Training in Knee Osteoarthritis

Feasibility of High Intensity Interval Training in Knee Osteoarthritis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03281668
Enrollment
29
Registered
2017-09-13
Start date
2017-11-01
Completion date
2018-11-09
Last updated
2019-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

Knee osteoarthritis

Brief summary

The focus of this pilot study is to evaluate the feasibility of utilizing an evidenced-based high intensity interval training program (HIIT) to improve physical function in patients with knee osteoarthritis (OA).

Detailed description

All participants will be assigned to the single-arm of the study in which all participants will receive 12 weeks of HIIT, delivered twice per week. The primary outcome will examine the feasibility and acceptability of the 12 week HIIT program in patients with knee OA symptoms ranging from mild to severe. The investigators will determine adherence to and tolerability of HIIT, acceptability, and recruitment and retention rates during the 12 week program. Additional outcomes will include physical function, knee OA symptomatic burden (pain), static standing balance, isometric knee extensor and flexor strength, cardiorespiratory fitness, and body composition.

Interventions

BEHAVIORALHigh intensity interval training (HIIT)

Each training session for High Intensity Interval Training will consist of a 3-5 minute warm-up, followed by 10 repetitions of 1-minute bouts at individualized training intensity with 1-minute rest periods.

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single Group assignment

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* between the ages of 40 and 75 years old * body mass index of 18.5-50 kg/m² * exhibits symptomatic knee OA, defined as a diagnosis of knee OA, as identified from University of North Carolina electronic medical records, and current knee symptoms in at least one knee, having a minimum score of 6 out of 20 on the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) pain subscale.

Exclusion criteria

* individuals diagnosed with a cardiovascular condition restricting exercise * individuals currently meeting Department of Health and Human Services Guidelines for physical activity (≥ 150 minutes per week * individuals currently doing HIIT * individuals currently participating in physical therapy for knee OA * individuals currently participating in another OA intervention study * received a corticosteroid or hyaluronic acid intra-articular injection in the knee during the previous 3 weeks or scheduled for during the intervention * diagnosis of gout in the knee * diagnosis of rheumatoid arthritis * diagnosis of fibromyalgia * other systemic rheumatic disease * severe dementia or other memory loss * active diagnosis of psychosis or uncontrolled substance abuse disorder * hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months * total joint replacement knee surgery, other knee surgery, meniscus tear, or anterior cruciate ligament (ACL) tear in the past 6 months * on a waiting list for total joint replacement * severely impaired hearing or speech * pregnant or planning to become pregnant while enrolled in the study * inability to speak English * serious or terminal illness as indicated by referral to hospice or palliative care * nursing home residence * inability to ride a stationary bike * any other health problems that would prohibit safe participation in the study * EKG results EKG suggesting the individual would not be able to safely participate in this study

Design outcomes

Primary

MeasureTime frameDescription
Percent of Potential Participants Screened for the Study Who Are EnrolledBaselineNumber of participants screened and enrolled divided by the total number of participants screened
Percentage of Enrolled Participants Retained at the End of the StudyStudy completion (12 weeks)Number of participants who completed the study (baseline through 12 week assessments) divided by the total number of enrolled participants with baseline assessments

Secondary

MeasureTime frameDescription
Total Number of Training Weeks Completed12 weeksTotal number of training weeks (up to 12 weeks possible)
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score From Baseline to 12 WeeksBaseline,12 weeksThe WOMAC, a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items), will be used to measure overall symptomatic burden of knee osteoarthritis (OA). Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a total WOMAC score ranging from 0 (no problems) to 96 (extreme problems). A higher score means a worse outcome.
Change in WOMAC Pain Subscale From Baseline to 12 WeeksBaseline,12 weeksThe WOMAC pain subscale contains 5 items about knee pain. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no pain) to 20 (extreme pain). A higher score means more severe pain.
Change in WOMAC Function Subscale From Baseline to 12 WeeksBaseline, 12 weeksThe WOMAC function subscale contains 17 items about knee function during daily activities. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no problems with function) to 68 (extreme problems with function). A higher score means worse function.
Change in 20m Fast Paced Walk TestBaseline, 12 weeksMeasure of the ability to walk quickly over short distances. Participants walk at fast pace that is timed over 2 x 10m.
Change in Number of Chair Stand Repetitions CompletedBaseline, 12 weeksNumber of chair stand repetitions completed in 30 seconds
Change in Stair Climb TestBaseline, 12 weeksTime in seconds to ascend and descend a flight of stairs
Change in Timed Up and GoBaseline, 12 weeksTime in seconds to rise from a chair, walk 3 m, turn, walk back to chair, and sit down
Average Number of Training Sessions Completed Per WeekWeekly measures for 12 consecutive weeksUp to 2 training sessions were possible each week over the 12 week intervention
Change in Semi-tandem StandBaseline, 12 weeksHeel of one foot placed to the side of the big toe of the other foot, for up to 10 seconds
Change in Tandem StandBaseline, 12 weeksOne foot in front of the other, heel touching toe, for up to 10 seconds
Change in One Leg StandBaseline, 12 weeksOne leg stand for up to 30 seconds
Change in Cardiorespiratory FitnessBaseline, 12 weeksMeasure by peak oxygen consumption (VO2peak),to identify fitness level and evaluate cardiovascular effects. Test will establish individual training intensity.
Change in Whole Body Fat MassBaseline, 12 weeksfat mass in kilograms, measured with dual energy x-ray absorptiometry (DXA)
Change in Lean Body MassBaseline, 12 weekslean body mass in kilograms, measured with DXA
Change in Visceral FatBaseline, 12 weeksvisceral fat in kilograms, measured with DXA
Change in Knee StrengthBaseline, 12 weeksHumac isokinetic dynamometer to measure isokinetic power and isometric strength of knee flexors extensors
Change in Feet Together StandBaseline, 12 weeksFeet together stand for up to 10 seconds without assistive device
Total Number of Training Sessions Completed12 weeksTotal number of training sessions completed out of up to 24 sessions (2 per week over 12 weeks)

Countries

United States

Participant flow

Participants by arm

ArmCount
Intervention
Intervention consists of High Intensity Interval Training (HIIT) session which is af 3-5 minute warm up, followed by 10 repetitions of 1 minute bouts at individualized training intensity with 1 minute rest periods. High intensity interval training (HIIT): Each training session for High Intensity Interval Training will consist of a 3-5 minute warm-up, followed by 10 repetitions of 1-minute bouts at individualized training intensity with 1-minute rest periods.
29
Total29

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up1
Overall StudyPhysician Decision1
Overall Studyscheduling conflict, family circumstance2
Overall StudyWithdrawal by Subject4

Baseline characteristics

CharacteristicIntervention
Age, Continuous63 years
BMI31.8 kg/m^2
STANDARD_DEVIATION 6.5
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
27 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
1 Participants
Race (NIH/OMB)
Black or African American
7 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
20 Participants
Region of Enrollment
United States
29 Participants
Sex: Female, Male
Female
19 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 29
other
Total, other adverse events
0 / 29
serious
Total, serious adverse events
0 / 29

Outcome results

Primary

Percentage of Enrolled Participants Retained at the End of the Study

Number of participants who completed the study (baseline through 12 week assessments) divided by the total number of enrolled participants with baseline assessments

Time frame: Study completion (12 weeks)

ArmMeasureValue (NUMBER)
InterventionPercentage of Enrolled Participants Retained at the End of the Study72.4 percentage of participants
Primary

Percent of Potential Participants Screened for the Study Who Are Enrolled

Number of participants screened and enrolled divided by the total number of participants screened

Time frame: Baseline

ArmMeasureValue (NUMBER)
InterventionPercent of Potential Participants Screened for the Study Who Are Enrolled19.3 percentage of participants
Secondary

Average Number of Training Sessions Completed Per Week

Up to 2 training sessions were possible each week over the 12 week intervention

Time frame: Weekly measures for 12 consecutive weeks

ArmMeasureValue (MEAN)Dispersion
InterventionAverage Number of Training Sessions Completed Per Week1.9 training sessions per weekStandard Deviation 0.24
Secondary

Change in 20m Fast Paced Walk Test

Measure of the ability to walk quickly over short distances. Participants walk at fast pace that is timed over 2 x 10m.

Time frame: Baseline, 12 weeks

Population: Originally planned to have participants perform 40-meter walk; however, due to lab space constraints, this was altered to a 20-meter walk instead.

ArmMeasureValue (MEAN)
InterventionChange in 20m Fast Paced Walk Test-1.13 seconds
Secondary

Change in Cardiorespiratory Fitness

Measure by peak oxygen consumption (VO2peak),to identify fitness level and evaluate cardiovascular effects. Test will establish individual training intensity.

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Cardiorespiratory Fitness0.14 change in liters/minute
Secondary

Change in Feet Together Stand

Feet together stand for up to 10 seconds without assistive device

Time frame: Baseline, 12 weeks

Population: All participants were able to complete Feet Together Stand at baseline and 12 weeks (no change).

ArmMeasureValue (MEAN)
InterventionChange in Feet Together Stand0.00 change in seconds
Secondary

Change in Knee Strength

Humac isokinetic dynamometer to measure isokinetic power and isometric strength of knee flexors extensors

Time frame: Baseline, 12 weeks

ArmMeasureGroupValue (MEAN)
InterventionChange in Knee StrengthRight knee flexors3.34 change in maximum kilograms
InterventionChange in Knee StrengthLeft knee flexors-0.84 change in maximum kilograms
InterventionChange in Knee StrengthRight knee extensors9.99 change in maximum kilograms
InterventionChange in Knee StrengthLeft knee extensors9.86 change in maximum kilograms
Secondary

Change in Lean Body Mass

lean body mass in kilograms, measured with DXA

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Lean Body Mass-0.12 kilogram (kg)
Secondary

Change in Number of Chair Stand Repetitions Completed

Number of chair stand repetitions completed in 30 seconds

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Number of Chair Stand Repetitions Completed2.6 number of chair stands
Secondary

Change in One Leg Stand

One leg stand for up to 30 seconds

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in One Leg Stand3.41 change in seconds
Secondary

Change in Semi-tandem Stand

Heel of one foot placed to the side of the big toe of the other foot, for up to 10 seconds

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Semi-tandem Stand0.52 change in seconds
Secondary

Change in Stair Climb Test

Time in seconds to ascend and descend a flight of stairs

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Stair Climb Test-1.42 change in seconds
Secondary

Change in Tandem Stand

One foot in front of the other, heel touching toe, for up to 10 seconds

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Tandem Stand0.39 change in seconds
Secondary

Change in Timed Up and Go

Time in seconds to rise from a chair, walk 3 m, turn, walk back to chair, and sit down

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Timed Up and Go-0.58 change in seconds
Secondary

Change in Visceral Fat

visceral fat in kilograms, measured with DXA

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Visceral Fat-0.19 kilogram (kg)
Secondary

Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score From Baseline to 12 Weeks

The WOMAC, a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items), will be used to measure overall symptomatic burden of knee osteoarthritis (OA). Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a total WOMAC score ranging from 0 (no problems) to 96 (extreme problems). A higher score means a worse outcome.

Time frame: Baseline,12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Total Score From Baseline to 12 Weeks-9.2 percentage change in score
Secondary

Change in Whole Body Fat Mass

fat mass in kilograms, measured with dual energy x-ray absorptiometry (DXA)

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in Whole Body Fat Mass-0.28 kilogram (kg)
Secondary

Change in WOMAC Function Subscale From Baseline to 12 Weeks

The WOMAC function subscale contains 17 items about knee function during daily activities. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no problems with function) to 68 (extreme problems with function). A higher score means worse function.

Time frame: Baseline, 12 weeks

ArmMeasureValue (MEAN)
InterventionChange in WOMAC Function Subscale From Baseline to 12 Weeks-6.3 percentage change in score
Secondary

Change in WOMAC Pain Subscale From Baseline to 12 Weeks

The WOMAC pain subscale contains 5 items about knee pain. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no pain) to 20 (extreme pain). A higher score means more severe pain.

Time frame: Baseline,12 weeks

ArmMeasureValue (MEAN)
InterventionChange in WOMAC Pain Subscale From Baseline to 12 Weeks-1.7 percentage change in score
Secondary

Total Number of Training Sessions Completed

Total number of training sessions completed out of up to 24 sessions (2 per week over 12 weeks)

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
InterventionTotal Number of Training Sessions Completed19.4 training sessionsStandard Deviation 7.4
Secondary

Total Number of Training Weeks Completed

Total number of training weeks (up to 12 weeks possible)

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
InterventionTotal Number of Training Weeks Completed11.4 weeksStandard Deviation 1.47

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026